Foxd3	O
Promotes	O
Exit	O
from	O
Naive	O
Pluripotency	O
through	O
Enhancer	O
Decommissioning	O
and	O
Inhibits	O
Germline	O
Specification	O
.	O


Following	O
implantation	O
,	O
mouse	O
epiblast	B-TISSUE
cells	E-TISSUE
transit	O
from	O
a	O
naive	O
to	O
a	O
primed	O
state	O
in	O
which	O
they	O
are	O
competent	O
for	O
both	O
somatic	S-TISSUE
and	O
primordial	B-TISSUE
germ	I-TISSUE
cell	E-TISSUE
(	O
PGC	S-TISSUE
)	O
specification	O
.	O


Using	O
mouse	O
embryonic	B-TISSUE
stem	I-TISSUE
cells	E-TISSUE
as	O
an	O
in	O
vitro	O
model	O
to	O
study	O
the	O
transcriptional	O
regulatory	O
principles	O
orchestrating	O
peri	O
-	O
implantation	O
development	O
,	O
here	O
we	O
show	O
that	O
the	O
transcription	O
factor	O
Foxd3	O
is	O
necessary	O
for	O
exit	O
from	O
naive	O
pluripotency	O
and	O
progression	O
to	O
a	O
primed	O
pluripotent	O
state	O
.	O


During	O
this	O
transition	O
,	O
Foxd3	O
acts	O
as	O
a	O
repressor	O
that	O
dismantles	O
a	O
significant	O
fraction	O
of	O
the	O
naive	O
pluripotency	O
expression	O
program	O
through	O
decommissioning	O
of	O
active	O
enhancers	O
associated	O
with	O
key	O
naive	O
pluripotency	O
and	O
early	O
germline	O
genes	O
.	O


Subsequently	O
,	O
Foxd3	O
needs	O
to	O
be	O
silenced	O
in	O
primed	O
pluripotent	B-TISSUE
cells	E-TISSUE
to	O
allow	O
re	O
-	O
activation	O
of	O
relevant	O
genes	O
required	O
for	O
proper	O
PGC	S-TISSUE
specification	O
.	O


Our	O
findings	O
therefore	O
uncover	O
a	O
cycle	O
of	O
activation	O
and	O
deactivation	O
of	O
Foxd3	O
required	O
for	O
exit	O
from	O
naive	O
pluripotency	O
and	O
subsequent	O
PGC	S-TISSUE
specification	O
.	O
